Verdera HC, Kuranda K, Mingozzi F. AAV vector immunogenicity in humans: a long journey to successful gene transfer. Mol Ther. 2020;28:723–46.

Article  CAS  Google Scholar 

Whitehead M, Osborne A, Yu-Wai-Man P, Martin K. Humoral immune responses to AAV gene therapy in the ocular compartment. Biol Rev. 2021;96:1616–44.

Article  CAS  Google Scholar 

Chandler LC, McClements ME, Yusuf IH, Martinez-Fernandez de la Camara C, MacLaren RE, Xue K. Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina. Mol Ther Methods Clin Dev. 2021;22:52–65.

Article  CAS  Google Scholar 

Samulski R, Zhu X, Xiao X, Brook J, Housman D, Epstein N. Corrigendum: Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 1992;11:1228.

Article  CAS  Google Scholar 

Fuller-Carter PI, Basiri H, Harvey AR, Carvalho LS. Focused update on AAV-based gene therapy clinical trials for inherited retinal degeneration. BioDrugs. 2020;34:763–81.

Article  Google Scholar 

Kuzmin DA, Shutova MV, Johnston NR, Smith OP, Fedorin VV, Kukushkin YS, et al. The clinical landscape for AAV gene therapies. Nat Rev Drug Discov. 2021;20:173–4.

Article  CAS  Google Scholar 

Mendell JR, Al-Zaidy SA, Rodino-Klapac LR, Goodspeed K, Gray SJ, Kay CN, et al. Current clinical applications of in vivo gene therapy with AAVs. Mol Ther. 2021;29:464–88.

Article  CAS  Google Scholar 

Au HKE, Isalan M, Mielcarek M. Gene therapy advances: a meta-analysis of AAV usage in clinical settings. Front Med. 2021;8:809118.

Article  Google Scholar 

Buck TM, Wijnholds J. Recombinant adeno-associated viral vectors (rAAV)-vector elements in ocular gene therapy clinical trials and transgene expression and bioactivity assays. Int J Mol Sci. 2020;21:E4197.

Article  Google Scholar 

Lebherz C, Maguire A, Tang W, Bennett J, Wilson JM. Novel AAV serotypes for improved ocular gene transfer. J Gene Med. 2008;10:375–82.

Article  CAS  Google Scholar 

Pang J, Lauramore A, Deng W, Li Q, Doyle TJ, Chiodo V, et al. Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration. Vis Res. 2008;48:377–85.

Article  CAS  Google Scholar 

Hellström M, Ruitenberg MJ, Pollett MA, Ehlert EME, Twisk J, Verhaagen J, et al. Cellular tropism and transduction properties of seven adeno-associated viral vector serotypes in adult retina after intravitreal injection. Gene Ther. 2009;16:521–32.

Article  Google Scholar 

Harvey AR, Kamphuis W, Eggers R, Symons NA, Blits B, Niclou S, et al. Intravitreal injection of adeno-associated viral vectors results in the transduction of different types of retinal neurons in neonatal and adult rats: a comparison with lentiviral vectors. Mol Cell Neurosci. 2002;21:141–57.

Article  CAS  Google Scholar 

Nickells RW, Schmitt HM, Maes ME, Schlamp CL. AAV2-mediated transduction of the mouse retina after optic nerve injury. Invest Ophthalmol Vis Sci. 2017;58:6091–104.

Article  CAS  Google Scholar 

Lee SH, Yang JY, Madrakhimov S, Park HY, Park K, Park TK. Adeno-associated viral vector 2 and 9 transduction is enhanced in streptozotocin-induced diabetic mouse retina. Mol Ther Methods Clin Dev. 2019;13:55–66.

Article  CAS  Google Scholar 

Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV, Bennicelli J, et al. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther. 2005;12:1072–82.

Article  CAS  Google Scholar 

Le Meur G, Weber M, Péréon Y, Mendes-Madeira A, Nivard D, Deschamps J-Y, et al. Postsurgical assessment and long-term safety of recombinant adeno-associated virus–mediated gene transfer into the retinas of dogs and primates. Arch Ophthalmol. 2005;123:500–6.

Article  Google Scholar 

Rodger J, Drummond ES, Hellström M, Robertson D, Harvey AR. Long-term gene therapy causes transgene-specific changes in the morphology of regenerating retinal ganglion cells. PLoS ONE. 2012;7:e31061.

Article  CAS  Google Scholar 

LeVaillant CJ, Sharma A, Muhling J, Wheeler LP, Cozens GS, Hellström M, et al. Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF. Mol Ther Methods Clin Dev. 2016;3:16078.

Article  Google Scholar 

Russell S, Bennett J, Wellman JA, Chung DC, Yu Z-F, Tillman A, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet. 2017;390:849–60.

Article  CAS  Google Scholar 

Andrews MR. Gene therapy in the CNS—one size does not fit all. Gene Ther. 2021;28:393–5.

Dong J-Y, Fan P-D, Frizzell RA. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum Gene Ther. 1996;7:2101–12.

Article  CAS  Google Scholar 

Wu Z, Yang H, Colosi P. Effect of genome size on AAV vector packaging. Mol Ther. 2010;18:80–6.

Article  CAS  Google Scholar 

Ye L, Gu L, Caprioli J, Piri N. RNA-binding protein Rbpms is represented in human retinas by isoforms A and C and its transcriptional regulation involves Sp1-binding site. Mol Genet Genomics. 2018;293:819–30.

Article  CAS  Google Scholar 

Simpson EM, Korecki AJ, Fornes O, McGill TJ, Cueva-Vargas JL, Agostinone J, et al. New MiniPromoter Ple345 (NEFL) drives strong and specific expression in retinal ganglion cells of mouse and primate retina. Hum Gene Ther. 2019;30:257–72.

Article  CAS  Google Scholar 

Hanlon KS, Chadderton N, Palfi A, Blanco Fernandez A, Humphries P, Kenna PF, et al. A novel retinal ganglion cell promoter for utility in AAV vectors. Front Neurosci. 2017;11:521.

Article  Google Scholar 

Millington-Ward S, Chadderton N, Berkeley M, Finnegan LK, Hanlon KS, Carrigan M, et al. Novel 199 base pair NEFH promoter drives expression in retinal ganglion cells. Sci Rep. 2020;10:16515.

Article  CAS  Google Scholar 

de Leeuw CN, Korecki AJ, Berry GE, Hickmott JW, Lam SL, Lengyell TC, et al. rAAV-compatible MiniPromoters for restricted expression in the brain and eye. Mol Brain. 2016;9:52.

Article  Google Scholar 

Smith CA, Chauhan BC. In vivo imaging of adeno-associated viral vector labelled retinal ganglion cells. Sci Rep. 2018;8:1490.

Article  Google Scholar 

Korecki AJ, Cueva-Vargas JL, Fornes O, Agostinone J, Farkas RA, Hickmott JW, et al. Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Müller glial, and PAX6 cells. Gene Ther. 2021;28:351–72.

Article  CAS  Google Scholar 

Scalabrino ML, Boye SL, Fransen KMH, Noel JM, Dyka FM, Min SH, et al. Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness. Hum Mol Genet. 2015;24:6229–39.

Article  CAS  Google Scholar 

Chaffiol A, Caplette R, Jaillard C, Brazhnikova E, Desrosiers M, Dubus E, et al. A new promoter allows optogenetic vision restoration with enhanced sensitivity in macaque retina. Mol Ther. 2017;25:2546–60.

Article  CAS  Google Scholar 

Wang Q, Zhuang P, Huang H, Li L, Liu L, Webber HC, et al. Mouse γ-synuclein promoter-mediated gene expression and editing in mammalian retinal ganglion cells. J Neurosci. 2020;40:3896–914.

Article  CAS  Google Scholar 

Boyd RF, Sledge DG, Boye SL, Boye SE, Hauswirth WW, Komáromy AM, et al. Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs. Gene Ther. 2016;23:223–30.

Article  CAS  Google Scholar 

Choi VW, Bigelow CE, McGee TL, Gujar AN, Li H, Hanks SM, et al. AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout mice. Mol Ther Methods Clin Dev. 2015;2. https://doi.org/10.1038/mtm.2015.22.

Fujita K, Nishiguchi KM, Shiga Y, Nakazawa T. Spatially and temporally regulated NRF2 gene therapy using Mcp-1 promoter in retinal ganglion cell injury. Mol Ther Methods Clin Dev. 2017;5:130–41.

Article  CAS  Google Scholar 

Khabou H, Garita-Hernandez M, Chaffiol A, Reichman S, Jaillard C, Brazhnikova E, et al. Noninvasive gene delivery to foveal cones for vision restoration. JCI Insight. 2018;3. https://doi.org/10.1172/jci.insight.96029.

Beltran WA, Cideciyan AV, Boye SE, Ye G-J, Iwabe S, Dufour VL, et al. Optimization of retinal gene therapy for X-linked retinitis pigmentosa due to RPGR mutations. Mol Ther. 2017;25:1866–80.

Article  CAS  Google Scholar 

Jüttner J, Szabo A, Gross-Scherf B, Morikawa RK, Rompani SB, Hantz P, et al. Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates and humans. Nat Neurosci. 2019;22:1345–56.

Article  Google Scholar 

Michalakis S, Mühlfriedel R, Tanimoto N, Krishnamoorthy V, Koch S, Fischer MD, et al. Restoration of cone vision in the CNGA3-/- mouse model of congenital complete lack of cone photoreceptor function. Mol Ther. 2010;18:2057–63.

Article  CAS  Google Scholar 

Aartsen WM, van Cleef KWR, Pellissier LP, Hoek RM, Vos RM, Blits B, et al. GFAP-driven GFP expression in activated mouse müller glial cells aligning retinal blood vessels following intravitreal injection of AAV2/6 vectors. PLoS ONE. 2010;5:e12387.

Article  Google Scholar 

Lu Q, Ganjawala TH, Ivanova E, Cheng JG, Troilo D, Pan Z-H. AAV-mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primates. Gene Ther. 2016;23:680–9.

Article  CAS  Google Scholar 

Miyadera K, Santana E, Roszak K, Iffrig S, Visel M, Iwabe S, et al. Targeting ON-bipolar cells by AAV gene therapy stably reverses LRIT3-congenital stationary night blindness. Proc Natl Acad Sci USA. 2022;119:e2117038119.

Article  CAS  Google Scholar 

Fagoe ND, Eggers R, Verhaagen J, Mason MRJ. A compact dual promoter adeno-associated viral vector for efficient delivery of two genes to dorsal root ganglion neurons. Gene Ther. 2014;21:242–52.

Article  CAS  Google Scholar 

Nieuwenhuis B, Haenzi B, Hilton S, Carnicer-Lombarte A, Hobo B, Verhaagen J, et al. Optimization of adeno-associated viral vector-mediated transduction of the corticospinal tract: comparison of four promoters. Gene Ther. 2021;28:56–74.

Article  CAS  Google Scholar 

Osborne A, Hopes M, Wright P, Broadway